From: MAP4K4: an emerging therapeutic target in cancer
Name
Type
Specificity
Biological/Preclinical disease model
Clinical trial
Ref.
GNE-495
KI
MAP4K4
Angiogenesis in mouse model
NA
[12, 53]
GNE-220
[12]
PF-6260933
Vascular inflammation, atherosclerosis
[18, 54]
4-Hydroxy-2-pyridone
Neuroblastoma cell
[55]